These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16470423)

  • 41. Heterotopic ossification after total hip arthroplasty: risk factors and prevention.
    Vastel L; Kerboull L; Anract P; Kerboull M
    Rev Rhum Engl Ed; 1998 Apr; 65(4):238-44. PubMed ID: 9599792
    [TBL] [Abstract][Full Text] [Related]  

  • 42. No difference between two doses of diclofenac in prophylaxis of heterotopic ossifications after total hip arthroplasty.
    Sell S; Phillips O; Handel M
    Acta Orthop Scand; 2004 Feb; 75(1):45-9. PubMed ID: 15022805
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevention of heterotopic ossification in high-risk patients with total hip arthroplasty: the experience of a combined therapeutic protocol.
    Pakos EE; Pitouli EJ; Tsekeris PG; Papathanasopoulou V; Stafilas K; Xenakis TH
    Int Orthop; 2006 Apr; 30(2):79-83. PubMed ID: 16482442
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Indomethacin for prevention of heterotopic ossification after hip arthroplasty. A randomized comparison between 4 and 8 days of treatment.
    Dorn U; Grethen C; Effenberger H; Berka H; Ramsauer T; Drekonja T
    Acta Orthop Scand; 1998 Apr; 69(2):107-10. PubMed ID: 9602763
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Effect of NSAID Prophylaxis and Operative Variables on Heterotopic Ossification After Hip Arthroscopy.
    Beckmann JT; Wylie JD; Kapron AL; Hanson JA; Maak TG; Aoki SK
    Am J Sports Med; 2014 Jun; 42(6):1359-64. PubMed ID: 24664136
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Eight days of naproxen therapy can prevent heterotopic ossification after total hip alloplasty].
    Gebuhr PH; Wilbek H; Soelberg M
    Ugeskr Laeger; 1996 Feb; 158(8):1076-8. PubMed ID: 8638341
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Total hip arthroplasty with cement and without acetabular bone graft for severe hip dysplasia. A concise follow-up, at a minimum of twenty years, of a previous report.
    Klapach AS; Callaghan JJ; Miller KA; Goetz DD; Sullivan PM; Pedersen DR; Johnston RC
    J Bone Joint Surg Am; 2005 Feb; 87(2):280-5. PubMed ID: 15687148
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Minimum ten-year follow-up of cemented total hip replacement in patients with osteonecrosis of the femoral head.
    Fyda TM; Callaghan JJ; Olejniczak J; Johnston RC
    Iowa Orthop J; 2002; 22():8-19. PubMed ID: 12180617
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Short-term results of modular extensively porous-coated revision stem in revision total hip arthroplasty].
    Weng XS; Li JW; Qiu GX; Zhao H; Jin J; Lin J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):182-7. PubMed ID: 15171558
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacological treatment of heterotopic ossification following hip and acetabular surgery.
    Macfarlane RJ; Ng BH; Gamie Z; El Masry MA; Velonis S; Schizas C; Tsiridis E
    Expert Opin Pharmacother; 2008 Apr; 9(5):767-86. PubMed ID: 18345954
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Total hip arthroplasty and femoral head osteonecrosis in renal transplant recipients].
    Stromboni M; Menguy F; Hardy P; Leparc JM; Lortat-Jacob A; Benoit J
    Rev Chir Orthop Reparatrice Appar Mot; 2002 Sep; 88(5):467-74. PubMed ID: 12399711
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Minimum 20-year follow-up results of revision total hip arthroplasty with improved cementing technique.
    Trumm BN; Callaghan JJ; George CA; Liu SS; Goetz DD; Johnston RC
    J Arthroplasty; 2014 Jan; 29(1):236-41. PubMed ID: 23759117
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevention of heterotopic ossification in hip arthroplasty. The influence of the duration of treatment.
    Vastel L; Kerboull L; Dejean O; Courpied JP; Kerboull M
    Int Orthop; 1999; 23(2):107-10. PubMed ID: 10422027
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Heterotopic bone formation in total hip arthroplasty: predisposing factors, classification and the significance for clinical outcome.
    Schara K; Herman S
    Acta Chir Orthop Traumatol Cech; 2001; 68(2):105-8. PubMed ID: 11706718
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Primary total hip arthroplasty with a flattened press-fit acetabular component in osteoarthritis and inflammatory arthritis: a prospective study on 416 hips with 6-10 years follow-up.
    Zwartelé RE; Olsthoorn PG; Pöll RG; Brand R; Doets HC
    Arch Orthop Trauma Surg; 2008 Dec; 128(12):1379-86. PubMed ID: 18758793
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Heterotopic ossification in patients with hip osteoarthritis below forty years old after total hip replacement.
    Koczy B; Stołtny T; Swiderski M; Pyda M; Pajak J; Spindel J; Wawrzynek W; Miszczyk L; Kasperczyk S; Widuchowski J
    Ortop Traumatol Rehabil; 2009; 11(5):458-66. PubMed ID: 19920288
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Non-steroidal anti-inflammatory drugs, cyclooxygenase-2 and the bone healing process.
    Vuolteenaho K; Moilanen T; Moilanen E
    Basic Clin Pharmacol Toxicol; 2008 Jan; 102(1):10-4. PubMed ID: 17973900
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevention of heterotopic ossification with irradiation after total hip arthroplasty. Radiation therapy with a single dose of eight hundred centigray administered to a limited field.
    Pellegrini VD; Konski AA; Gastel JA; Rubin P; Evarts CM
    J Bone Joint Surg Am; 1992 Feb; 74(2):186-200. PubMed ID: 1541613
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Heterotopic ossification after total hip arthroplasty: When is development completed?
    Willburger RE; Brinkhoff F; Nottenkämper J; Krapp J; Oberberg S
    J Orthop Surg Res; 2022 Mar; 17(1):147. PubMed ID: 35248082
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Selective COX-2 inhibitor versus nonselective COX-1 and COX-2 inhibitor in the prevention of heterotopic ossification after total hip arthroplasty: a meta-analysis of randomised trials.
    Xue D; Zheng Q; Li H; Qian S; Zhang B; Pan Z
    Int Orthop; 2011 Jan; 35(1):3-8. PubMed ID: 19830425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.